High quality research reports across a broad range of industries

Brexit and the Healthcare Industry – Implications for Pharma, Q1 2018

It has been almost two years since the UK voted to leave the EU. Businesses were told a vote to leave the EU would drive the UK into a severe recession, yet markets are up. Negotiations are ongoing to determine the UK’s post-Brexit relationship with the EU.

This report provides an assessment of how the pharmaceutical industry expects Brexit to affect the healthcare sector, both within and outside of Britain. This study will be repeated at the end of Q2 this year, to gauge the changing sentiment towards Brexit from within the healthcare industry.

This report provides in-house analyst expertise on the results of a 10 minutes survey of 155 GlobalData Pharma clients and prospects which was fielded from April 9, 2018 to April 23, 2018. Participants answered questions about how they expected Brexit to affect the healthcare sector, both within and outside of the UK. Components of the slide deck include –